Zentalis Pharmaceuticals, Inc.ZNTLNASDAQ
Loading
Current Ratio Over TimeFair Value
Percentile Rank50
3Y CAGR-2.8%
5Y CAGR+9.6%
Year-over-Year Change
Current ratio (current assets / current liabilities)
3Y CAGR
-2.8%/yr
Annual compound
5Y CAGR
+9.6%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive growthFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 7.32 | +2.3% |
| 2023 | 7.16 | -10.2% |
| 2022 | 7.98 | -0.1% |
| 2021 | 7.98 | -33.8% |
| 2020 | 12.07 | +160.9% |
| 2019 | 4.62 | +7.6% |
| 2018 | 4.30 | - |